Stay updated on Nivolumab for Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Meningioma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:02:27.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T10:19:48.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.9%
    Check dated 2025-05-30T06:07:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T02:22:57.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:27:09.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect the opening of accrual to Cohort 2 of a clinical trial for recurrent meningioma, with a focus on the drug nivolumab. Additionally, the principal investigator's name has been clarified, and the revision number has been updated.
    Difference
    56%
    Check dated 2025-04-16T20:37:23.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Meningioma Clinical Trial page.